Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Willis

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Neurology|October 31, 2015
Prognosis in multiple sclerosis and the unveiling of pathogenic cluesS Healy, M D Willis, N P Robertson
British Journal of Hospital Medicine (London, England : 2005)|May 14, 2013
Subacute sclerosing panencephalitis: rapidly progressive cognitive decline in a young patientM D Willis, P Rudge, R J Walters
Journal of Agricultural and Food Chemistry|May 1, 1983
Exposure of pesticide applicators to nitrofen: influence of formulation, handling systems, and protective garmentsA R Putnam, M D Willis, L K Binning, et al.
QJM : Monthly Journal of the Association of Physicians|February 13, 2014
VGKC-complex antibody encephalitisM D Willis, L Jones, A Vincent, et al.
Practical Neurology|June 28, 2014
Reversible brainstem dysfunction from spinal arterio-venous fistulaM D Willis, T Amato-Watkins, M Zaben, et al.
European Journal of Neurology|September 9, 2014
Site-specific clinical disease onset in multiple sclerosisM D Willis, K E Harding, M Wardle, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 31, 2015
Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohortM D Willis, K E Harding, T P Pickersgill, et al.
European Journal of Neurology|January 17, 2018
Multiple sclerosis: long-term outcomes in ethnic minorities. Analysis of a UK population-based registryM O Alsaeed, K E Harding, O H Williams, et al.
Multiple Sclerosis and Related Disorders|September 11, 2022
Multiple sclerosis and COVID-19: Assessing risk perception, patient behaviors and access to disease-modifying therapiesR Beesley, M Cauchi, L Davies, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Neurology|October 31, 2015
Prognosis in multiple sclerosis and the unveiling of pathogenic cluesS Healy, M D Willis, N P Robertson
British Journal of Hospital Medicine (London, England : 2005)|May 14, 2013
Subacute sclerosing panencephalitis: rapidly progressive cognitive decline in a young patientM D Willis, P Rudge, R J Walters
Journal of Agricultural and Food Chemistry|May 1, 1983
Exposure of pesticide applicators to nitrofen: influence of formulation, handling systems, and protective garmentsA R Putnam, M D Willis, L K Binning, et al.
QJM : Monthly Journal of the Association of Physicians|February 13, 2014
VGKC-complex antibody encephalitisM D Willis, L Jones, A Vincent, et al.
Practical Neurology|June 28, 2014
Reversible brainstem dysfunction from spinal arterio-venous fistulaM D Willis, T Amato-Watkins, M Zaben, et al.
European Journal of Neurology|September 9, 2014
Site-specific clinical disease onset in multiple sclerosisM D Willis, K E Harding, M Wardle, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 31, 2015
Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohortM D Willis, K E Harding, T P Pickersgill, et al.
European Journal of Neurology|January 17, 2018
Multiple sclerosis: long-term outcomes in ethnic minorities. Analysis of a UK population-based registryM O Alsaeed, K E Harding, O H Williams, et al.
Multiple Sclerosis and Related Disorders|September 11, 2022
Multiple sclerosis and COVID-19: Assessing risk perception, patient behaviors and access to disease-modifying therapiesR Beesley, M Cauchi, L Davies, et al.
Pageof 2